CRx acquires the Macaluso Group

ConnectiveRx acquires The Macalusco Group to enhance specialty product reimbursement and customer support.

ConnectiveRx, a market-leader in patient and provider engagement services with hub, adherence and market access solutions for specialty and branded medications today announced the acquisition of The Macaluso Group (TMG), a technology-driven provider of specialty pharmacy benefits. This acquisition, which was completed on May 16, 2018, will further build upon ConnectiveRx's buy and bill reimbursement services while advancing the brand's payment platforms and customer service capabilities. 

Let's talk shop.